First approval of a complement C3 inhibitor opens up autoimmune and inflammatory opportunities

Authors

Keywords

Journal

Volume -, Issue -, Pages -

Publisher

Springer Science and Business Media LLC

Online

2021-05-26

DOI

10.1038/d41573-021-00094-8

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now